Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Grouzmann

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|May 4, 2020
Endocrine causes of secondary hypertensionEric Grouzmann
Clinical Chemistry|August 4, 2020
Commentary on A Rare and Unusual Cause of Unilateral Ureteric Obstruction in a ChildEric Grouzmann
Best Practice & Research. Clinical Endocrinology & Metabolism|October 8, 2013
Determination of catecholamines in plasma and urineEric Grouzmann, Faiza Lamine
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?Eric Grouzmann, Thierry Buclin
Clinical Chemistry|March 16, 2022
LC-MS/MS Peptide Assay Validation: A Plea for Robust Stability StudiesEric Grouzmann, Philippe J Eugster
Hypertension (Dallas, Tex. : 1979)|July 8, 2009
Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedemaEric Grouzmann, Françoise Livio, Thierry Buclin
Revue Medicale Suisse|March 4, 2010
[Angioedema during ACE and DPP-4 inhibition]Bernard Waeber, Thierry Buclin, Eric Grouzmann
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2008
Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administrationEric Grouzmann, Thierry Buclin, Jérôme Biollaz
Clinical Chemistry|October 1, 2008
Calibration of fractionated metanephrines in urine: still an issue?Eric Grouzmann, Bruno Mathian, Thierry Buclin
Lancet (London, England)|January 30, 2007
GliptinsEric Grouzmann, Thierry Buclin, Jérôme Biollaz
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Best Practice & Research. Clinical Endocrinology & Metabolism|May 4, 2020
Endocrine causes of secondary hypertensionEric Grouzmann
Clinical Chemistry|August 4, 2020
Commentary on A Rare and Unusual Cause of Unilateral Ureteric Obstruction in a ChildEric Grouzmann
Best Practice & Research. Clinical Endocrinology & Metabolism|October 8, 2013
Determination of catecholamines in plasma and urineEric Grouzmann, Faiza Lamine
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?Eric Grouzmann, Thierry Buclin
Clinical Chemistry|March 16, 2022
LC-MS/MS Peptide Assay Validation: A Plea for Robust Stability StudiesEric Grouzmann, Philippe J Eugster
Hypertension (Dallas, Tex. : 1979)|July 8, 2009
Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedemaEric Grouzmann, Françoise Livio, Thierry Buclin
Revue Medicale Suisse|March 4, 2010
[Angioedema during ACE and DPP-4 inhibition]Bernard Waeber, Thierry Buclin, Eric Grouzmann
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2008
Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administrationEric Grouzmann, Thierry Buclin, Jérôme Biollaz
Clinical Chemistry|October 1, 2008
Calibration of fractionated metanephrines in urine: still an issue?Eric Grouzmann, Bruno Mathian, Thierry Buclin
Lancet (London, England)|January 30, 2007
GliptinsEric Grouzmann, Thierry Buclin, Jérôme Biollaz
Pageof 11